2. 您的位置
3. 首页
4. 会议论文
5. Mechanistic Understanding of Mechanisms of Toxic Action of Dioscorea bulbifera L

Mechanistic Understanding of Mechanisms of Toxic Action of Dioscorea bulbifera L

来源 :2017年第三届岭南国际DMPK论坛 | 被引量 : 0次 | 上传用户：gaga1235

【摘 要】

：

Dioscorea bulbifera L (Huang-Yao-Zi) is widely used in China as an herbal medicine in treatment of thyroid diseases. However, the herb has also been known for i

【作 者】

：

Jiang Zheng 

【机 构】

：

ShenyangPharmaceuticalUniversityandGuizhouMedicalUniversity

【出 处】

：

2017年第三届岭南国际DMPK论坛

【发表日期】

：

2017年12期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Dioscorea bulbifera L (Huang-Yao-Zi) is widely used in China as an herbal medicine in treatment of thyroid diseases. However, the herb has also been known for its hepatotoxicity, and the mechanisms of toxic action remain unknown.

其他文献

Personalized therapy and pharmacogenomics of platinum-based chemotherapy in lung cancer

会议

Drug Metabolism and Activity-based Omics

会议

Consideration of DMPK in preparation formula and BE Study

会议

Research strategies and prospect for DMPK of nano-particle drugs

　　Recent years, more and more new intravenous nanoparticles have been widely used in industry, such as polymer nanoparticles, micelles, nanocapsules, liposome

会议

Transporters-mediated drug-drug interaction/multidrug resistance and its molecular pharmacokinetic m

会议

The vital role of BBB P-glycoprotein in brain exposure and fetal respiratory depression of narcotic

会议

Stereoselectivity of Chiral Drug Metabolism

会议

Potential Therapeutic Target for Liver Fibrosis

会议

Liver humanized mice lacking murine P450 oxidoreductase in drug metabolism

Drug metabolism plays important roles in the drug development and drug toxicity. Species difference between the experimental animal models and humans is well–k

会议

CYP induction, the regulatory guidance, industrial practice, and case studies in INDNDA submission

Cytochrome P450 (CYP) induction is one of the two parts commonly involved in pharmacokinetic-based drug-drug interactions, besides the CYP inhibition.

会议